UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $22
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $23 to $22.
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $23 to $22.